Author
Cameron Gofton
Recent research
- Health & MedicineOpen access
Abstract Background Hepatitis B virus (HBV) reactivation is a well-recognised complication of immunosuppressive therapy, particularly following B-cell-depleting agents such as rituximab. Although several extrahepatic neurological manifestations of HBV have been described, concurr...